|
|
Article: OGD performs vital regulatory, educational functions.(Generic Drugs)(Office of Generic Drugs)
- Article from:
- Chain Drug Review
- Article date:
- September 27, 2004
CopyrightCOPYRIGHT 2004 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON -- Under the leadership of director Gary Buehler, the Office of Generic Drugs (OGD) is the regulatory sector of the Food and Drug Administration that perhaps interacts most frequently with generic drug companies.
The OGD operates with a staff of approximately 200 scientists, pharmacists and support personnel overseen by Buehler, a pharmacist by training who has extensive experience in and knowledge of the drug-review process and applicable laws and regulations.
The office expects to approve (or tentatively approve) about 400 applications by the end of its current fiscal year, compared with 373 in the previous period. More than 550 abbreviated ...